A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Name: A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing
Published: 2010
License: Public Domain

Teva Branded Pharmaceutical Products R&D, Inc. · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

asthma

asthma, dry powder inhaler, short-acting beta2-agonist, saba, bronchoconstriction, bronchodilation, bronchodilator, metered dose inhaler, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Related documents